Bosse T - Search Results

1

Biomarker Expression and Clinical Outcomes in International Study of Chemoradiation and Magnetic Resonance Imaging-Based Image-Guided Brachytherapy for Locally Advanced Cervical Cancer: BIOEMBRACE.

Chopra S, Bosse T, Horeweg N, Deodhar K, Menon S, Rafael T, Pai V, Rijstenberg L, van Kemenade F, Kannan S, Mahantshetty U, Segedin B, Huang F, Bruheim K, Perez M, Rai B, Tan LT, Giannakopoulos N, Schmid M, Tanderup K, Pötter R, Nout RA. Chopra S, et al. Among authors: bosse t. Int J Radiat Oncol Biol Phys. 2025 Jan 1;121(1):97-106. doi: 10.1016/j.ijrobp.2024.07.2316. Epub 2024 Jul 26. Int J Radiat Oncol Biol Phys. 2025. PMID: 39067486 Free article.

2

Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/β-catenin and P53 pathway activation.

Nout RA, Bosse T, Creutzberg CL, Jürgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, van der Steen-Banasik EM, van Eijk R, Ter Haar NT, Smit VT. Nout RA, et al. Among authors: bosse t. Gynecol Oncol. 2012 Sep;126(3):466-73. doi: 10.1016/j.ygyno.2012.05.012. Epub 2012 May 15. Gynecol Oncol. 2012. PMID: 22609107

3

Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer.

Bosse T, ter Haar NT, Seeber LM, v Diest PJ, Hes FJ, Vasen HF, Nout RA, Creutzberg CL, Morreau H, Smit VT. Bosse T, et al. Mod Pathol. 2013 Nov;26(11):1525-35. doi: 10.1038/modpathol.2013.96. Epub 2013 May 24. Mod Pathol. 2013. PMID: 23702729 Free article.

4

High concordance of molecular tumor alterations between pre-operative curettage and hysterectomy specimens in patients with endometrial carcinoma.

Stelloo E, Nout RA, Naves LC, Ter Haar NT, Creutzberg CL, Smit VT, Bosse T. Stelloo E, et al. Among authors: bosse t. Gynecol Oncol. 2014 May;133(2):197-204. doi: 10.1016/j.ygyno.2014.02.012. Epub 2014 Feb 18. Gynecol Oncol. 2014. PMID: 24556061

5

L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: pooled PORTEC trial results.

Bosse T, Nout RA, Stelloo E, Dreef E, Nijman HW, Jürgenliemk-Schulz IM, Jobsen JJ, Creutzberg CL, Smit VT. Bosse T, et al. Eur J Cancer. 2014 Oct;50(15):2602-10. doi: 10.1016/j.ejca.2014.07.014. Epub 2014 Aug 7. Eur J Cancer. 2014. PMID: 25126672

6

Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials.

Bosse T, Peters EE, Creutzberg CL, Jürgenliemk-Schulz IM, Jobsen JJ, Mens JW, Lutgens LC, van der Steen-Banasik EM, Smit VT, Nout RA. Bosse T, et al. Eur J Cancer. 2015 Sep;51(13):1742-50. doi: 10.1016/j.ejca.2015.05.015. Epub 2015 Jun 3. Eur J Cancer. 2015. PMID: 26049688 Clinical Trial.

7

Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer.

Van Gool IC, Stelloo E, Nout RA, Nijman HW, Edmondson RJ, Church DN, MacKay HJ, Leary A, Powell ME, Mileshkin L, Creutzberg CL, Smit VT, Bosse T. Van Gool IC, et al. Among authors: bosse t. Mod Pathol. 2016 Feb;29(2):174-81. doi: 10.1038/modpathol.2015.147. Epub 2016 Jan 8. Mod Pathol. 2016. PMID: 26743472 Free article.

8

Microsatellite instability derived JAK1 frameshift mutations are associated with tumor immune evasion in endometrioid endometrial cancer.

Stelloo E, Versluis MA, Nijman HW, de Bruyn M, Plat A, Osse EM, van Dijk RH, Nout RA, Creutzberg CL, de Bock GH, Smit VT, Bosse T, Hollema H. Stelloo E, et al. Among authors: bosse t. Oncotarget. 2016 Jun 28;7(26):39885-39893. doi: 10.18632/oncotarget.9414. Oncotarget. 2016. PMID: 27213585 Free PMC article.

9

Limited impact of intratumour heterogeneity on molecular risk assignment in endometrial cancer.

van Esterik M, Van Gool IC, de Kroon CD, Nout RA, Creutzberg CL, Smit VTHBM, Bosse T, Stelloo E. van Esterik M, et al. Among authors: bosse t. Oncotarget. 2017 Apr 11;8(15):25542-25551. doi: 10.18632/oncotarget.16067. Oncotarget. 2017. PMID: 28424422 Free PMC article.

10

Adjuvant therapy for high-risk endometrial cancer: recent evidence and future directions.

De Boer SM, Nout RA, Bosse T, Creutzberg CL. De Boer SM, et al. Among authors: bosse t. Expert Rev Anticancer Ther. 2019 Jan;19(1):51-60. doi: 10.1080/14737140.2019.1531708. Epub 2018 Oct 24. Expert Rev Anticancer Ther. 2019. PMID: 30295094 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

200 results

Search Page

Filters